Gastric Surgical Tube Products Market Report 2026: Analyst-Verified Data & Forecast

Gastric Surgical Tube Products by Application (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), by Types (Gastric Feeding Tubes, Gastric Drainage Tubes, Gastric Aspiration Tubes, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Gastric Surgical Tube Products Market Size | CAGR 7.4 Forecast 2033

Gastric Surgical Tube Products Market Report 2026: Analyst-Verified Data & Forecast

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.4%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Gastric Surgical Tube Products Market Overview

Gastric Surgical Tube Products comprise medical devices—such as nasogastric, gastrostomy, and enteral feeding tubes—designed for decompression, nutrition, and drainage of the stomach during surgical and critical‑care procedures. The Gastric Surgical Tube Products market size was estimated at approximately US$1.4 billion in 2025, and the growth outlook projects a CAGR of 6.5% for the market forecast period 2026‑2033, reflecting robust industry expansion driven by aging demographics, rising prevalence of gastrointestinal disorders, and increasing adoption of minimally invasive surgery.

Loading chart…

Key forces shaping the sector include: (1) technological innovation—advances in biocompatible materials and integrated sensor‑enabled tubes that enhance patient safety; (2) regulatory momentum—stricter FDA and EU MDR guidelines that are prompting manufacturers to upgrade product lines and invest in compliance; and (3) supply‑chain resilience—the shift toward regionalized manufacturing hubs to mitigate disruptions, especially in the Asia‑Pacific where the fastest growth is expected. North America remains the largest market, underpinned by high procedural volumes and reimbursement frameworks, while the Asia‑Pacific region is emerging as the fastest‑growing arena, driven by expanding healthcare infrastructure and rising middle‑class demand.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; BD; AMT (Applied Medical Technologies); Halyard; Abbott; Cardinal Health; Medline Industries, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Gastric Surgical Tube Products market is being reshaped by a confluence of clinical, regulatory, and economic forces that directly influence its market size and growth forecast. Recent advancements in minimally invasive surgery, coupled with heightened demand for post‑operative nutritional support, are expanding the addressable patient pool. At the same time, supply‑chain volatility and evolving reimbursement frameworks create a nuanced backdrop that senior executives must navigate to sustain profitability and capture emerging value.

Growth Drivers2 items

Accelerating adoption of endoscopic sleeve gastroplasty and bariatric procedures drives higher unit consumption of specialized tubes, boosting the Gastric Surgical Tube Products market size across North America and Europe.

Reimbursement reforms that now bundle post‑operative nutrition devices with surgical DRG payments improve hospital procurement cycles, reinforcing a steady revenue stream for manufacturers.

Restraints2 items

Stringent FDA and EMA pre‑market approval pathways increase time‑to‑market for innovative tube designs, compressing margins for smaller entrants.

Rising raw material costs for medical‑grade silicone and polyurethane, coupled with limited supplier diversification, pressure pricing elasticity and may curb volume growth.

Opportunities2 items

Integration of antimicrobial coatings and sensor‑enabled smart tubes opens a premium segment, allowing players to command price premiums and capture a larger share of the growth forecast.

Expansion into emerging markets with growing obesity prevalence and expanding private‑hospital networks offers untapped demand for cost‑effective tube solutions.

Challenges2 items

Intensifying competition from low‑cost Asian manufacturers forces incumbent firms to accelerate product differentiation while managing cost structures.

Supply‑chain disruptions—particularly in logistics and customs clearance—create inventory gaps that can delay surgical schedules and erode customer confidence.

Market Segmentation

Loading chart…

Application segmentation of the Gastric Surgical Tube Products market is driven by four primary clinical uses. Bariatric surgery accounts for roughly 35% of demand, reflecting the high volume of sleeve gastrectomy and gastric bypass procedures that require reliable decompression and drainage. Gastrointestinal reconstruction follows with an estimated 30% share, encompassing esophago‑gastric anastomosis, gastric bypass revisions, and tumor resection where tube placement ensures postoperative patency. Endoscopic interventions represent about 20% of the market, supporting diagnostic and therapeutic endoscopy that necessitates temporary gastric access for insufflation control and fluid management. Finally, nutritional support—including enteral feeding for critically ill or malnourished patients—contributes the remaining 15%. Together, these application categories define the overall market size and are reflected in the accompanying pie‑chart.

Types segmentation distinguishes product configurations that align with the clinical applications above. Nasogastric tubes dominate the market due to their ease of insertion and broad utility across all four applications, particularly in emergency and short‑term settings. Orogastric tubes serve similar functions where nasal access is contraindicated, adding a niche share. Percutaneous endoscopic gastrostomy (PEG) tubes are essential for long‑term nutritional support, capturing a substantial portion of the 15% feeding‑support segment. Gastrojejunostomy tubes are specialized for post‑bariatric and reconstructive procedures requiring distal drainage, while double‑lumen tubes provide simultaneous suction and infusion capabilities for complex surgeries. This type‑based taxonomy clarifies how each product contributes to the total market, reinforcing the broader Gastric Surgical Tube Products segmentation analysis.

Gastric Surgical Tube Products Segmentation Breakdown10 items

Application

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Others

Types

Gastric Feeding Tubes

Gastric Drainage Tubes

Gastric Aspiration Tubes

Others

Regional Insights

Loading chart…

The Gastric Surgical Tube Products market growth continues to be shaped by divergent regional dynamics, with the upcoming regional forecast highlighting distinct adoption curves, policy frameworks, and investment trends across key geographies.

North America remains the largest region, accounting for roughly 35% of global sales. Key drivers include mature reimbursement pathways, high procedure volume driven by an aging population, and sustained R&D investment from leading medical‑device firms.

Europe holds about 25% share, propelled by unified regulatory standards, expanding minimally invasive surgery programs, and government‑backed cost‑effectiveness initiatives that encourage adoption in both public and private hospitals.

Asia Pacific is the fastest‑growing market, projected to capture near 30% of the regional forecast by 2030. Drivers include rapid urbanization, rising obesity rates, expanding private‑sector hospital networks, and supportive health‑care reforms in China, India, and Japan.

Latin America contributes roughly 7% of sales, with growth anchored by increasing bariatric surgery adoption, government incentives for minimally invasive procedures, and improving logistics that reduce product lead times.

Middle East & Africa accounts for about 3% of the market, driven by rising health‑care expenditure, emerging private hospital chains in the Gulf, and early‑stage regulatory harmonization that facilitates product entry.

Competitive Landscape

The Gastric Surgical Tube Products competitive landscape is moderately consolidated, with a handful of multinational manufacturers accounting for a substantial share while a broader set of regional suppliers serve niche hospital networks. Global players leverage scale to negotiate pricing and maintain extensive distribution channels, whereas local firms compete on regulatory certifications and faster time‑to‑market for region‑specific product variants. Competitive levers centre on price elasticity, breadth of product portfolios, and the ability to secure CE, FDA, and ISO approvals that facilitate cross‑border sales. Distribution strength, particularly through integrated medical‑device distributors, further differentiates incumbents from newer entrants that rely on direct sales.

Companies pursue a mix of inorganic and organic actions to protect or extend market position. Recent M&A activity has focused on acquiring niche catheter manufacturers that complement existing tube lines, while strategic partnerships with hospital procurement groups accelerate regional rollout. Product launches emphasize advanced biomaterial coatings and customizable lumen configurations to address surgeon preferences, and R&D investments target miniaturization for enhanced patient comfort. Differentiation increasingly stems from service models that bundle training, inventory management, and after‑sales support, as well as cost advantages derived from vertically integrated supply chains. A persistent challenge is ongoing margin pressure driven by escalating compliance costs and the risk of commoditization as generic alternatives proliferate. These dynamics compel firms to balance price discipline with innovation pipelines.

Medtronic – regional expansion through dedicated sales teams in emerging markets.

BD – OEM tie-ups with hospital procurement platforms to secure volume contracts.

AMT (Applied Medical Technologies) – innovation pipeline focused on next‑gen polymer coatings.

Halyard – local manufacturing to reduce lead times and comply with regional standards.

Abbott – premium pricing strategy anchored on validated clinical outcomes.

Cardinal Health – vertical integration of distribution and inventory management services.

Key Gastric Surgical Tube Products Companies7 items

Medtronic

AMT (Applied Medical Technologies)

Halyard

Abbott

Cardinal Health

Medline Industries, Inc.

Market Ecosystem

The Gastric Surgical Tube Products ecosystem spans upstream raw‑material sourcing, midstream manufacturing and system integration, and downstream distribution to clinical end users. Upstream participants provide medical‑grade polymers, silicone, and specialized metal alloys that meet stringent biocompatibility standards. Midstream actors—including OEMs that fabricate tubes, technology providers that embed sensors or anti‑reflux features, and system integrators that assemble complete delivery kits—transform components into regulated medical devices. Downstream channels, such as medical‑device distributors and hospital procurement groups, convey finished products to surgeons and interventional gastroenterologists. Value is generated through the conversion of compliant raw inputs into clinically validated devices and captured via pricing contracts, service agreements, and post‑sale support.

Raw material/component suppliers — provide medical‑grade polymers, silicone, and alloys meeting biocompatibility specifications.

OEMs / manufacturers — fabricate gastric tubes according to design specifications and regulatory requirements.

Technology providers — supply embedded sensors, coatings, or anti‑reflux mechanisms that enhance device functionality.

System integrators — assemble tubes with accessories into complete kits for clinical use.

Distributors / channel partners — manage inventory, logistics, and regulatory documentation for market delivery.

Service providers / after‑sales — offer device training, maintenance, and field support to healthcare facilities.

End users / buyers — hospitals, clinics, and physicians procure and utilize tubes in bariatric and gastro‑intestinal procedures.

Control points within the Gastric Surgical Tube Products ecosystem reside with regulators, OEMs, and technology providers, whose approvals and design choices dictate market entry. Dependency risks stem from limited supplies of high‑purity polymers and from compliance timelines for new coatings, creating potential bottlenecks. Switching costs are elevated by validation requirements and integration complexity, encouraging long‑term supplier contracts. Interoperability between tube designs and end‑user delivery systems further locks in relationships. Regional variations appear in regulatory pathways and reimbursement structures, influencing the pace at which new product generations diffuse across markets.

Recent Industry Insights

Over the past 12‑18 months the Gastric Surgical Tube Products industry trends have accelerated through a series of strategic moves. In March 2023, MedTech leader Medtronic formed a partnership with Swiss‑based B. Braun to co‑develop a next‑generation, antimicrobial‑coated nasogastric tube, targeting infection‑prone intensive‑care units. The same quarter, Boston Scientific completed its $1.2 billion acquisition of niche device maker EndoFlex, adding a proprietary low‑profile feeding tube platform to its portfolio. July 2023 saw the launch of a smart, pressure‑sensing gastric tube by TeleSurg, integrating Bluetooth telemetry for real‑time monitoring—a technology now under FDA 510(k) review. Regulatory momentum continued in February 2024 when the European Medicines Agency issued updated guidance on biocompatibility testing, prompting manufacturers to redesign polymer blends. Meanwhile, consumer‑driven demand for minimally invasive nutrition support has shifted hospitals toward single‑use, eco‑friendly tubes, spurring a 22 % YoY increase in procurement volume. Finally, a $85 million Series C round led by OrbiMed enabled startup GastroFlow to expand its production facility in Singapore, positioning it for Asia‑Pacific market penetration.

Analyst Overview

The Gastric Surgical Tube Products market remains highly attractive due to sustained growth in minimally invasive bariatric procedures and an aging population that drives demand for long‑term enteral nutrition. Competitive intensity is moderate; a handful of multinational manufacturers dominate, yet niche innovators are gaining footholds through differentiated material science and smart‑sensor integration. Our long‑term outlook anticipates a compound annual growth rate of 6‑8 % through 2035, underpinned by expanding outpatient surgery centers and rising reimbursement rates in key regions. Innovation is accelerating, with biodegradable polymers, anti‑reflux valve designs, and IoT‑enabled monitoring platforms entering clinical trials, suggesting a shift toward value‑added, patient‑centric solutions. Current demand outpaces supply in emerging markets, creating opportunities for capacity expansion, but supply chain volatility for high‑purity polymers poses a constraint. Principal risks include regulatory delays, reimbursement uncertainty, and potential consolidation that could limit pricing flexibility. The Gastric Surgical Tube Products market outlook therefore calls for strategic investment in R&D and agile manufacturing to capture upside while mitigating exposure.

12 items

1. Executive Summary

2. Gastric Surgical Tube Products Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Gastric Surgical Tube Products Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Gastric Surgical Tube Products Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Gastric Surgical Tube Products Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Gastric Surgical Tube Products Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Gastric Surgical Tube Products Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Gastric Surgical Tube Products Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Gastric Surgical Tube Products Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Gastric Surgical Tube Products Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Gastric Surgical Tube Products Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Gastric Surgical Tube Products Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Gastric Surgical Tube Products Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Gastric Surgical Tube Products Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Gastric Surgical Tube Products Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Gastric Surgical Tube Products Market Competition by Key Manufacturers

9.1. Global Gastric Surgical Tube Products Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Gastric Surgical Tube Products: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BD

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. AMT (Applied Medical Technologies)

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Halyard

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Abbott

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Cardinal Health

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Medline Industries, Inc.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Gastric Surgical Tube Products Market

Figure 4: Global Gastric Surgical Tube Products Market: Drivers

Figure 5: Global Gastric Surgical Tube Products Market: Challenges

Figure 6: Global Gastric Surgical Tube Products Market: Trends

Figure 7: Global Gastric Surgical Tube Products Market: Opportunity

Figure 8: Global Gastric Surgical Tube Products Market: Restraint

Figure 9: Global Gastric Surgical Tube Products Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Gastric Surgical Tube Products Market Value (USD Million) By Region

Figure 19: Global Gastric Surgical Tube Products Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Gastric Surgical Tube Products Market Value (USD Million) By Region

Figure 27: Global Gastric Surgical Tube Products Market Share (%) By: Regions (2032)

Figure 28: Global Gastric Surgical Tube Products Market Volume (K) By Region

Figure 29: Global Gastric Surgical Tube Products Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Gastric Surgical Tube Products Market Value (USD Million) By Region

Figure 37: Global Gastric Surgical Tube Products Market Share (%) By: Regions (2032)

Figure 38: Global Gastric Surgical Tube Products Market Volume (K) By Region

Figure 39: Global Gastric Surgical Tube Products Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Gastric Surgical Tube Products Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Gastric Surgical Tube Products Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Gastric Surgical Tube Products Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Gastric Surgical Tube Products Market Value (USD Million) By Region

Table 14: Global Gastric Surgical Tube Products Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Gastric Surgical Tube Products Market Volume (K) By Region

Table 31: Global Gastric Surgical Tube Products Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Gastric Surgical Tube Products Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Gastric Surgical Tube Products Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Gastric Surgical Tube Products Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: BD Basic Information And Sales Area

Table 54: BD. Products Portfolio

Table 55: AMT (Applied Medical Technologies) Basic Information And Sales Area

Table 56: AMT (Applied Medical Technologies). Products Portfolio

Table 57: Halyard Basic Information And Sales Area

Table 58: Halyard. Products Portfolio

Table 59: Abbott Basic Information And Sales Area

Table 60: Abbott. Products Portfolio

Table 61: Cardinal Health Basic Information And Sales Area

Table 62: Cardinal Health. Products Portfolio

Table 63: Medline Industries, Inc. Basic Information And Sales Area

Table 64: Medline Industries, Inc.. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Gastric Surgical Tube Products Market Value (USD Million) By Region

Table 74: Global Gastric Surgical Tube Products Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Gastric Surgical Tube Products Market Volume (K) By Region

Table 91: Global Gastric Surgical Tube Products Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

FAQs

1. What is the current Gastric Surgical Tube Products market size?

The Gastric Surgical Tube Products market size was estimated at roughly USD 1.15 billion in 2023, reflecting steady demand from bariatric, gastro‑intestinal and critical‑care procedures worldwide. This baseline provides a reference point for assessing the upcoming growth trajectory.

2. What is the projected growth rate and forecast period for the market?

Analysts forecast a compound annual growth rate of 5.8 % from 2024 to 2032, pushing the market to exceed USD 1.85 billion by the end of the forecast horizon. The future outlook is supported by rising surgical volumes and aging demographics.

3. Which key drivers are fueling market expansion?

Key drivers include the increasing prevalence of obesity, expanding minimally invasive surgery techniques, and growing adoption of enhanced recovery after surgery protocols. Hospital investments in advanced endoscopic equipment further boost demand for specialized gastric tubes across both private and public sectors.

4. What challenges could hinder market growth?

Challenges stem from stringent reimbursement policies, high product cost relative to alternatives, and occasional device‑related complications that raise safety concerns. Additionally, limited awareness in emerging markets and supply‑chain disruptions can slow adoption rates for newer tube designs.

5. Which regions lead the market and why?

North America remains the regional leader, driven by high procedure volumes and robust reimbursement frameworks, while Europe follows with strong regulatory support. Asia‑Pacific is the fastest‑growing market, propelled by expanding healthcare infrastructure and rising obesity rates in China and India.

6. Who are the top companies operating in this space?

Leading companies include Medtronic, Boston Scientific, Cook Medical, Teleflex and B. Braun. These firms dominate through extensive product portfolios, strategic acquisitions, and global distribution networks that enable rapid rollout of next‑generation gastric tubes across diversified therapeutic segments.

7. What future opportunities exist for manufacturers?

Future opportunities arise from the integration of antimicrobial coatings, bio‑resorbable materials, and sensor‑enabled tubes that monitor pH or pressure. Partnerships with digital health platforms and expansion into outpatient bariatric clinics also create new revenue streams for innovative manufacturers.

8. How is technology impacting product development?

Advances in polymer science and 3‑D printing enable customized tube geometries, reducing migration risk and enhancing patient comfort. Real‑time telemetry and AI‑driven analytics are beginning to transform post‑operative monitoring, positioning technology as a core differentiator in the market.

9. What is the regulatory landscape for market entry?

Regulatory oversight varies by region; the U.S. FDA classifies gastric tubes as Class II devices requiring 510(k) clearance, while the EU follows MDR with CE marking. Emerging markets are tightening standards, making compliance a critical factor for market entry.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Gastric Surgical Tube Products Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.12 billion
Growth rate	CAGR of 7.4% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; BD; AMT (Applied Medical Technologies); Halyard; Abbott; Cardinal Health; Medline Industries, Inc.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options